홈 › 암 (전체) › 오하이오 › Cincinnati
OH Cincinnati의 암 (전체) 임상 시험
암 (전체) 관련 연구 28개가 Cincinnati 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
피험자 모집 중3상
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Saint Elizabeth Healthcare Edgewood, Edgewood · 8마일 거리
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
피험자 모집 중3상
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8마일 거리
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
피험자 모집 중
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
피험자 모집 중3상
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15마일 거리
Pan Tumor Rollover Study
피험자 모집 중2상
- Oncology Hematology Care, Cincinnati
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
피험자 모집 중2상
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15마일 거리
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
피험자 모집 중2/3상
- Oncology Hematology Care, Inc., Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
피험자 모집 중3상
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15마일 거리
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
피험자 모집 중3상
- Research Site, Edgewood · 8마일 거리
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
피험자 모집 중관찰 연구
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
피험자 모집 중3상
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- 외 1개
International Rare Brain Tumor Registry
피험자 모집 중관찰 연구
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
피험자 모집 중3상
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
피험자 모집 중1/2상
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Registry Study for Radiation Therapy Outcomes
피험자 모집 중관찰 연구
- University of Cincinnati Medical Center, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
피험자 모집 중관찰 연구
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
피험자 모집 중1/2상
- University of Cincinnati, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
피험자 모집 중2상
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
피험자 모집 중2상
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
피험자 모집 중관찰 연구
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
피험자 모집 중1상
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
피험자 모집 중관찰 연구
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
피험자 모집 중관찰 연구
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
피험자 모집 중
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15마일 거리
다른 도시의 암 (전체) 시험
- Houston, TX연구 123개
- New York City, NY연구 111개
- Boston, MA연구 86개
- Los Angeles, CA연구 73개
- Nashville, TN연구 64개
- Philadelphia, PA연구 60개
- Washington, DC연구 60개
- Durham, NC연구 59개
- Chicago, IL연구 52개
- Atlanta, GA연구 50개
- Seattle, WA연구 50개
- Arlington, VA연구 49개
Cincinnati의 다른 연구
- 비소세포폐암연구 35개
- 유방암연구 25개
- 심부전연구 24개
- 대장직장암연구 21개
- 비만연구 20개
- 전이성 암연구 20개
- 급성 골수성 백혈병연구 20개
- 폐암연구 19개
- 난소암연구 19개
- 전립선암연구 18개
- 흑색종연구 17개
- 다발성 골수종연구 17개
ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.